NCT01276288View on ClinicalTrials.gov

Pharmacodynamics and Pharmacokinetics of Empagliflozin and Torasemide in Patients With Type 2 Diabetes

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

June 30, 2011

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

BI 10773

multiple oral doses

DRUG

hydrochlorothiazide

multiple oral doses

DRUG

torasemide

multiple oral doses

DRUG

BI 10773

multiple oral doses

DRUG

torasemide

multiple oral doses

DRUG

BI 10773

multiple oral doses

DRUG

hydrochlorothiazide

multiple oral doses

Trial Locations (1)

Unknown

1245.42.1 Boehringer Ingelheim Investigational Site, Neuss

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY